MSD to invest HUF 9bn in R&D in Hungary

…activities involved 500 health professionals and more than 800 patients at 200 venues. Last December, the HIPA said that from 2017 onwards it would offer additional incentives to companies which establish their R&D centres in Hungary (including grants of up to 25% of the eligible costs).

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.